Full Press Release Details
GAITHERSBURG, Md., Feb. 07, 2022 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) will host a conference call on Thursday, February 24, 2022 at 5:00 pm eastern time to discuss the financial results for the fourth quarter 2021, recent business developments, financial outlook for full year 2022, and revenue guidance for the first quarter of 2022.
This conference call can be accessed live by telephone or by webcast:
Teleconference Information:
Dial in number – toll-free: (855) 766-6521
Dial in number – toll: (262) 912-6157
Conference ID: 7619558
Webcast Information:
Visit https://edge.media-server.com/mmc/p/tfd93ojy for the live webcast.
A replay of the call can be accessed from the Investors page of the Emergent website.
About Emergent BioSolutions
Vice President, Investor Relations
Senior Director, Media Relations